medicine-news-1/staar-surgical-generates-cash-from-operations-during-second-quarter-53456-6/;msg90356
| We're sorry, that page (http://www.bio-medicine.org/medicine-news-1/staar-surgical-generates-cash-from-operations-during-second-quarter-53456-6/;msg90356) was not found. Search medicine news 1 staar surgical generates cash from operations during second quarter 53456 6 ;msg90356 at Google Search medicine news 1 staar surgical generates cash from operations during second quarter 53456 6 ;msg90356 at Yahoo Search medicine news 1 staar surgical generates cash from operations during second quarter 53456 6 ;msg90356 at Msn |
Breaking Biology Technology:EntreMed Reports Receipt of Third Quarter Royalty Payment 2Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 2Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 3miRagen announces discovery of key microRNA implicated in Lou Gehrig's disease 2Amount of gene surplus determines severity of mental retardation in males 2
[0] EntreMed Reports Receipt of Third Quarter Royalty Payment[0] Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering[0] miRagen announces discovery of key microRNA implicated in Lou Gehrig's disease[0] Amount of gene surplus determines severity of mental retardation in males
Breaking Medicine Technology:Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 3DecisionView Launches StudyOptimizer(TM) 4 2DecisionView Launches StudyOptimizer(TM) 4 3Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 2Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 3TGen and USC researchers find genetic markers to help fight diabetes 49031 1TGen and USC researchers find genetic markers to help fight diabetes 49031 2TGen and USC researchers find genetic markers to help fight diabetes 49031 3UCLA cancer researchers develop model that may help identify cancer stem cells 8850 1UCLA cancer researchers develop model that may help identify cancer stem cells 8850 2UCLA cancer researchers develop model that may help identify cancer stem cells 8850 3Tropicana Launches Get Your Fruit On 21 Campaign to Help Narrow the Gap in the Nations Fruit Consumption 49028 1Tropicana Launches Get Your Fruit On 21 Campaign to Help Narrow the Gap in the Nations Fruit Consumption 49028 2Tropicana Launches Get Your Fruit On 21 Campaign to Help Narrow the Gap in the Nations Fruit Consumption 49028 3Tropicana Launches Get Your Fruit On 21 Campaign to Help Narrow the Gap in the Nations Fruit Consumption 49028 4
[0] Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug[0] DecisionView Launches StudyOptimizer(TM) 4[0] Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign
| Copyright © 2003-2007 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |